Variable | Single screening group (N = 200) | Continuous screening group (N = 195) | P Value |
---|---|---|---|
Age, median (range) | 35.7(9–64) | 37.2(12–67) | 0.319 |
Sex, N (%) | Â | Â | 0.530 |
 Male | 115(57.5) | 106(54.4) |  |
 Female | 85(42.5) | 89(45.6) |  |
Underlying disease, N (%) | Â | Â | 0.208 |
 AML | 78(39.0) | 66(33.8) |  |
 ALL | 62(31.0) | 66(33.8) |  |
 MDS | 18(9.0) | 9(4.6) |  |
 NHL/HL | 21(10.5) | 20(10.3) |  |
 MM | 12(6.0) | 20(10.3) |  |
 others | 9(4.5) | 14(7.2) |  |
Type of HSCT, N (%) | Â | Â | 0.697 |
 Allogeneic | |||
 MUD | 13(6.5) | 14(7.2) |  |
 Haplo | 127(63.5) | 117(60.0) |  |
 Sib | 37(18.5) | 34(17.4) |  |
 Autologous | 23(11.5) | 30(15.4) |  |